Trelegy ellipta 100-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FDB4Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,163
Award facts
- Contract value 100% obligated
- $35,162.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) valued at $35,162.65 for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, awarded on January 23, 2026, with an ultimate completion date of January 26, 2026, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. This delivery order is issued under Amerisourcebergen Drug Corp's parent company, Cencora, Inc. (doing business as Amerisourcebergen), which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of an extensive range of medications and medical supplies to support military healthcare programs worldwide.
The award supports the Defense Logistics Agency's medical supply chain operations, which furnish critical pharmaceutical products to military treatment facilities, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. Amerisourcebergen Drug Corp's participation in this competitive federal procurement landscape demonstrates its capability to efficiently deliver essential pharmaceutical commodities across multiple therapeutic domains to meet government medical requirements.
Quick answers
Who was awarded contract SPE2DR26FDB4Q?
SPE2DR26FDB4Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FDB4Q worth?
The government has obligated $35,163 on SPE2DR26FDB4Q.
Is contract SPE2DR26FDB4Q an order under another contract?
Yes. SPE2DR26FDB4Q is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDB4Q competed?
The extent of competition for SPE2DR26FDB4Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award